nucleic
acid
amplif
techniqu
commonli
use
current
diagnos
viral
diseas
manag
patient
kind
ill
techniqu
rapid
unconvent
rout
develop
last
year
discoveri
introduct
sever
assay
clinic
diagnosi
increas
number
commerci
avail
method
facilit
use
technolog
major
laboratori
worldwid
technolog
reduc
use
techniqu
viral
cultur
base
method
serolog
assay
clinic
virolog
laboratori
moreov
nucleic
acid
amplif
techniqu
method
refer
also
use
assay
diagnosi
sever
diseas
introduct
techniqu
autom
provid
new
opportun
clinic
laboratori
affect
patient
care
main
object
perform
nucleic
acid
test
field
provid
time
result
use
highqual
patient
care
reason
cost
rapid
result
associ
improv
patient
care
use
amplif
techniqu
polymeras
chain
reaction
realtim
polymeras
chain
reaction
nucleic
acid
sequencebas
amplif
viru
detect
genotyp
quantif
advantag
like
high
sensit
reproduc
well
broad
dynam
rang
review
uptod
main
nucleic
acid
techniqu
clinic
applic
special
challeng
opportun
techniqu
current
provid
clinic
virolog
laboratori
molecular
diagnost
techniqu
viral
test
experi
rapid
develop
last
year
introduc
major
laboratori
new
way
diagnosi
human
pathogen
like
virus
field
molecular
microbiolog
present
mani
challeng
practic
laboratori
medicin
implement
like
autom
methodolog
introduct
fulli
autom
devic
faster
turnaround
time
allow
clinic
laboratori
necessari
tool
report
sensit
accur
result
physician
goal
perform
microbiolog
nucleic
acid
test
nat
mainli
provid
time
result
use
highqual
patient
care
reason
cost
rapid
result
obtain
nat
associ
improv
patient
care
empir
data
model
studi
find
faster
detect
enterovir
mening
use
nat
associ
reduc
length
stay
durat
antibiot
administr
well
substanti
cost
save
use
amplif
techniqu
polymeras
chain
reaction
pcr
realtim
pcr
nucleic
acid
sequencebas
amplif
nasba
viru
detect
genotyp
quantif
advantag
like
high
sensit
reproduc
well
broad
dynam
rang
great
number
qualit
quantit
molecular
viru
assay
mostli
address
correspond
author
microbiolog
unit
biotechnolog
area
hospit
de
ponient
ctra
de
almerimar
sn
el
ejido
spain
tel
email
fernandocobosspa
juntadeandalucia
base
pcr
technolog
describ
nasba
assay
could
identifi
activ
infect
detect
viral
messeng
rna
mrna
wide
use
test
clinic
viru
diagnosi
quantit
realtim
pcr
techniqu
mani
molecular
diagnost
method
replac
autom
devic
use
less
time
manipul
smaller
volum
liquid
provid
quantifi
result
better
precis
molecular
techniqu
revolution
diagnosi
infecti
diseas
particularli
diagnosi
viral
diseas
autom
method
provid
decreas
turnaround
time
low
contamin
risk
eas
perform
speed
well
abil
lower
detect
limit
diminish
cost
per
test
review
focus
applic
molecular
technolog
clinic
virolog
laboratori
tabl
summar
main
molecular
techniqu
use
clinic
virolog
nucleic
acid
probe
segment
dna
rna
label
radioisotop
enzym
chemiluminisc
molecul
bind
complementari
nucleic
acid
sequenc
microorgan
probe
use
identifi
virus
commonli
use
format
probe
hybrid
includ
liquidphas
solidphas
situ
hybrid
gener
techniqu
poor
analyt
sensit
could
use
situat
number
microorgan
larg
liquidphas
hybrid
assay
techniqu
singlestrand
dna
probe
label
acridinium
ester
incub
target
nucleic
acid
hybrid
step
probe
bind
measur
luminomet
solidphas
hybrid
target
nucleic
acid
bind
nitrocellulos
nylon
hybrid
probe
solut
identif
carri
mean
fluoresc
luminesc
color
develop
radioact
main
limit
assay
time
consumpt
complex
techniqu
applic
clinic
practic
limit
final
situ
hybrid
solidphas
hybrid
nucleic
acid
contain
cell
tissu
fix
microscop
slide
main
disadvantag
situ
hybrid
limit
access
target
nucleic
acid
cell
begin
molecular
diagnost
initi
end
eighti
develop
pcr
although
method
wide
use
nucleic
acid
amplif
techniqu
methodolog
develop
biochem
mechan
techniqu
base
target
signal
probe
amplif
signal
amplif
assay
signal
directli
proport
amount
target
sequenc
present
clinic
specimen
reduc
falseposit
result
due
cross
contamin
also
develop
quantit
assay
reliabl
branch
bdna
signal
amplif
system
consist
seri
hybrid
step
result
sandwich
complex
probe
target
sequenc
branch
structur
techniqu
multipl
targetspecif
probe
use
captur
nucleic
acid
onto
surfac
microwel
plate
initi
step
bdna
assay
ensur
viral
particl
disrupt
viral
rna
present
analysi
targetspecif
oligonucleotid
hybrid
target
nucleic
acid
region
hybrid
multipl
bdna
amplifi
molecul
creat
branch
structur
final
bdna
signal
chemiluminisc
product
reaction
signal
bdna
assay
proport
number
label
probe
bdna
assay
quantit
hepat
c
viru
hcv
rna
hepat
b
viru
hbv
dna
human
immunodefici
viru
type
rna
commerci
avail
bayer
healthcar
diagnost
divis
tarrytown
ny
detect
hcv
firstgener
bdna
assay
quantiplex
hcv
rna
assay
bayer
dynam
quantif
rang
human
plasma
x
x
hcv
rna
copiesml
genotyp
detect
use
assay
although
sensit
lower
genotyp
improv
detect
rate
hcv
genotyp
secondgener
assay
develop
quantiplex
hcv
rna
assay
bayer
howev
thirdgener
bdna
assay
hcv
hiv
develop
versant
hcv
rna
versant
rna
assay
bayer
use
isoc
isogsubstitut
oligonucleotid
reduc
nonspecif
hybrid
system
solut
hybridizationantibodi
captur
techniqu
use
chemiluminesc
detect
system
hybrid
molecul
dna
sampl
denatur
hybrid
specif
rna
probe
dnarna
hybrid
captur
antihybrid
antibodi
antibodi
conjug
detect
chemiluminesc
substrat
luminomet
serv
devic
measur
light
emit
hybrid
captur
assay
detect
human
papillomaviru
hpv
cytomegaloviru
cmv
clinic
specimen
current
commerci
avail
digen
corp
gaithersburg
md
techniqu
use
enzymemedi
process
enzym
synthes
sever
copi
target
nucleic
acid
amplif
product
detect
two
oligonucleotid
primer
bind
complementari
sequenc
final
result
product
million
copi
target
sequenc
possibl
contamin
fals
posit
result
must
reduc
special
laboratori
design
practic
workflow
pcr
allow
synthesi
million
copi
target
nucleic
acid
sequenc
chemic
reaction
occur
mean
action
dna
polymeras
copi
dna
strand
pcr
consist
mixtur
target
dna
two
oligonucleotid
primer
dna
polymeras
mixtur
deoxyribonucleotid
triphosph
dntp
mgcl
kcl
trishcl
buffer
reaction
mixtur
heat
cool
sever
cycl
programm
thermal
cycler
n
cycl
target
sequenc
amplifi
n
fold
pcr
reaction
detect
product
amplif
done
mean
sever
techniqu
eg
gel
analysi
colorimetr
detect
rtpcr
introduc
amplifi
rna
target
method
cdna
first
produc
rna
revers
transcript
cdna
amplifi
pcr
thermost
dna
polymeras
deriv
thermu
thermophilu
could
function
effici
rt
dna
polymeras
commerci
kit
avail
detect
hcv
rna
quantit
hcv
rna
clinic
specimen
roch
diagnost
indianapoli
ind
modal
pcr
increas
sensit
specif
techniqu
use
two
pair
amplif
primer
two
round
pcr
first
round
use
one
primer
pair
cycl
product
first
round
amplif
submit
second
round
amplif
second
pair
primer
major
disadvantag
nest
pcr
high
rate
contamin
reaction
mixtur
two
primer
set
design
amplif
differ
target
use
one
target
sequenc
clinic
specimen
coamplifi
singl
tube
howev
primer
use
must
care
select
order
similar
anneal
temperatur
lack
complementar
kind
pcr
less
sensit
pcr
singl
primer
set
multiplex
pcr
assay
viral
respiratori
pathogen
detect
viral
infect
central
nervou
system
develop
commerci
method
target
amplif
detect
step
occur
simultan
method
requir
special
thermal
cycler
monitor
fluoresc
emiss
sampl
comput
softwar
support
thermal
cycler
monitor
data
everi
cycl
gener
amplif
plot
reaction
pcr
product
detect
use
fluoresc
dye
preferenti
bind
doublestrand
dna
specif
realtim
pcr
also
increas
use
fluoresc
reson
energi
transfer
fret
probe
reaction
mixtur
anoth
approach
realtim
pcr
use
dual
hybrid
probe
use
two
special
design
sequencespecif
oligonucleotid
probe
final
detect
quantit
amplif
product
carri
molecular
beacon
realtim
pcr
decreas
time
requir
perform
nucleic
acid
assay
postpcr
process
step
main
advantag
method
also
decreas
contamin
possibl
quantit
applic
two
method
includ
group
nucleic
acid
sequencebas
amplif
nasba
transcriptionmedi
amplif
tma
isotherm
rna
amplif
method
model
retrovir
replic
method
rna
target
revers
transcrib
cdna
rna
copi
synthes
rna
polymeras
transcriptionbas
amplif
system
sever
characterist
requir
thermal
cycler
rapid
kinet
singlestrand
rna
product
requir
denatur
prior
detect
genprob
develop
tmabas
assay
detect
hcv
nasbabas
kit
develop
commerci
avail
kit
detect
quantit
rna
cmv
rna
detect
enteroviru
respiratori
syncyti
viru
rna
method
isotherm
templat
amplif
techniqu
use
detect
trace
amount
dna
rna
particular
sequenc
becton
dickinson
compani
spark
md
current
format
strand
displac
amplif
occur
two
phase
target
gener
exponenti
target
amplif
recent
strand
displac
amplif
adapt
quantit
rna
rtstrand
displac
amplif
use
determin
hiv
viral
load
method
differ
use
target
amplif
amplif
product
contain
sequenc
present
initi
probe
exampl
probe
amplif
method
ligas
chain
reaction
cycl
probe
technolog
cleavaseinvad
technolog
invad
assay
third
wave
technolog
madison
ws
base
probe
amplif
method
specif
recognit
particular
dna
structur
cleavas
member
famili
dna
polymeras
assay
two
primer
design
hybrid
target
sequenc
sever
method
use
detect
cleavag
product
fluoresc
reson
energi
transfer
fret
probe
second
invas
cleavag
reaction
detect
targetspecif
product
common
techniqu
use
fret
occur
due
interact
electron
excit
state
two
dye
molecul
fret
probe
pair
fluoresc
probe
place
close
proxim
excit
transfer
one
dye
molecul
without
emiss
photon
acceptor
fluorophor
emit
light
detect
specif
channel
technolog
current
avail
hcv
genotyp
ligas
chain
reaction
assay
base
ligat
two
adjac
synthet
oligonucleotid
primer
hybrid
one
strand
target
dna
second
pair
primer
use
cycl
reaction
use
thermost
dna
ligas
ligat
product
serv
templat
next
reaction
cycl
lead
exponenti
amplif
process
similar
pcr
amplif
detect
ligas
chain
reaction
product
could
carri
mean
sever
method
autoradiographi
fluoresc
one
advantag
fluoresc
detect
system
rel
easi
quantit
amount
ligas
chain
reaction
product
method
detect
ligas
chain
reaction
product
microtit
plate
also
use
lcr
assay
develop
detect
virus
hpv
hsv
hiv
cycl
probe
technolog
method
detect
quantif
low
amount
target
dna
reaction
carri
temperatur
allow
chimer
probe
anneal
singlestrand
target
dna
rnase
h
enzym
specif
degrad
rna
portion
dnarna
hybrid
cut
within
rna
portion
chimer
probe
shorter
probe
fragment
dissoci
target
regener
target
cycl
result
accumul
probe
fragment
detect
sinc
target
dna
amplifi
techniqu
show
low
background
moreov
cycl
probe
technolog
fast
linear
isotherm
simpl
compar
dna
detect
method
dna
array
dna
chip
collect
spot
attach
solid
support
spot
contain
one
singlestrand
dna
oligonucleotid
fragment
high
densiti
array
permit
attach
hundr
thousand
oligonucleotid
refer
microarray
label
amplif
product
hybrid
probe
hybrid
signal
map
sever
posit
within
array
pattern
hybrid
identifi
sequenc
pcr
number
probe
suffici
larg
result
hybrid
bound
probe
label
sequenc
sampl
appli
test
reveal
scan
imag
array
surfac
confoc
microscopi
use
scan
chip
detect
fluoresc
signal
reveal
hybrid
precis
locat
chip
mani
dna
sequenc
present
slide
possibl
microarray
analysi
test
multipl
virus
simultan
first
applic
diagnost
virolog
rapid
sequenc
detect
hiv
mutat
associ
resist
antiretrovir
drug
sinc
research
group
develop
microarray
detect
sever
virus
respiratori
virus
hepat
c
viru
viru
caus
cn
infect
microspherebas
suspens
array
technolog
luminex
xmap
tm
system
offer
platform
nucleic
acid
detect
advantag
includ
rapid
data
acquisit
excel
sensit
specif
multiplex
analysi
capabl
compar
planar
microarray
suspens
array
advantag
eas
use
low
cost
statist
superior
faster
hybrid
kinet
flexibl
array
prepar
system
incorpor
microspher
dy
two
spectral
differ
fluorochrom
array
creat
consist
distinct
microspher
set
specif
spectrum
third
fluorochrom
quantifi
biomolecular
interact
occur
microspher
surfac
microspher
pass
separ
laser
luminex
analyz
high
speed
digit
signal
process
classifi
microspher
base
spectral
signal
quantifi
reaction
surfac
thousand
microspher
analyz
per
second
result
analysi
system
capabl
analyz
report
lot
differ
reaction
assay
use
direct
dna
hybrid
competit
dna
hybrid
solutionbas
chemistri
microspher
captur
multiplex
assay
detect
quantit
viral
nucleic
acid
use
system
develop
hiv
hcv
hsv
high
specif
result
sinc
nucleic
acid
amplif
method
sever
disadvantag
requir
precis
thermal
cycl
isotherm
techniqu
introduc
diagnost
tool
due
simpl
oper
rapid
reaction
easi
detect
new
techniqu
requir
thermal
cycler
perform
use
heat
block
andor
water
bath
main
isotherm
method
includ
loopmedi
isotherm
amplif
lamp
helicasedepend
amplif
hda
method
improv
classic
pcr
reaction
simplic
accuraci
higher
amplif
effici
procedur
rapid
amplif
complet
less
hour
main
advantag
lamp
requir
thermal
cycler
amplif
carri
water
bath
heat
block
lamp
onestep
amplif
reaction
proce
isotherm
condit
chemistri
lamp
amplif
base
principl
strand
displac
reaction
describ
previous
mechan
consist
three
step
initi
noncycl
step
cyclic
amplif
step
elong
step
addit
revers
transcriptas
make
possibl
amplifi
cdna
rna
rtlamp
lamp
method
alreadi
use
emerg
human
viral
pathogen
dengu
sar
virus
also
rtlamp
assay
develop
influenza
b
virus
detect
well
cmv
hsv
vzv
bk
viru
hpv
hda
isotherm
amplif
method
similar
dna
replic
vivo
use
dna
helicas
separ
two
complementari
dna
strand
dsdna
extens
dna
polymeras
initi
heat
denatur
subsequ
thermocycl
necessari
entir
hda
reaction
perform
singl
uniform
temperatur
techniqu
provid
use
tool
amplifi
dna
vitro
isotherm
condit
hda
techniqu
develop
detect
sever
virus
differ
clinic
sampl
human
plasma
hsv
type
genit
lesion
implement
molecular
techniqu
platform
clinic
virolog
laboratori
diagnosi
need
requir
personnel
facil
requir
correct
work
flow
design
laboratori
worker
must
train
preanalyt
specimen
extract
process
analyt
procedur
profession
work
kind
laboratori
correct
train
experi
molecular
method
also
theoret
knowledg
molecular
virolog
major
manufactur
provid
overview
present
molecular
biolog
well
technic
inform
specif
test
platform
director
virolog
laboratori
provid
individu
train
molecular
virolog
laboratori
worker
success
perform
correct
molecular
test
import
keep
special
attent
maintain
strict
adher
standard
oper
procedur
sop
avoid
sampl
contamin
use
asept
techniqu
laboratori
must
avail
detail
sop
train
materi
checklist
techniqu
perform
laboratori
respect
fact
would
import
technic
expert
provid
refer
person
order
appli
methodolog
clinic
laboratori
laboratorydevelop
test
requir
technic
resourc
resolv
problem
relat
assay
avail
within
laboratori
order
minim
decreas
risk
specimen
contamin
necessari
physic
separ
process
well
reagent
equip
use
molecular
laboratori
laboratori
defin
work
area
gener
four
differ
work
area
recommend
reagent
prepar
area
prepar
pcr
master
mix
sampl
process
area
differ
procedur
perform
like
nucleic
acid
extract
target
load
area
specimen
ad
pcr
master
mix
amplif
area
thermocycl
probe
detect
perform
reagent
prepar
area
kept
free
specimen
dnarna
extract
number
tube
simultan
open
must
minim
order
avoid
crosscontamin
differ
sampl
import
issu
differ
devic
use
pcr
pipett
tube
reagent
dedic
exclus
work
area
reagent
prepar
aliquot
singl
use
small
volum
work
surfac
clean
use
reagent
elimin
nucleic
acid
recommend
must
follow
clean
instrument
process
block
instrument
surfac
part
glove
chang
frequent
least
begin
procedur
must
alway
chang
move
one
anoth
work
area
select
success
introduct
molecular
test
platform
virolog
laboratori
work
flow
implement
time
technolog
introduc
main
factor
establish
effect
work
flow
determin
arriv
time
specimen
number
sampl
test
clinic
urgenc
result
laboratori
function
laboratori
establish
work
flow
depend
techniqu
viral
determin
fact
individu
tabl
show
main
virus
could
diagnos
mean
molecular
techniqu
well
sampl
techniqu
appropri
cmv
infect
sever
clinic
present
nonspecif
viral
syndrom
ocular
congenit
diseas
infect
also
occur
cn
major
clinic
present
form
enceph
also
myeliti
radiculomyelopathi
mononeur
multiplex
studi
suggest
detect
cmv
dna
cerebrospin
fluid
csf
highli
sensit
specif
cmv
neurolog
diseas
cmv
dna
could
detect
convent
pcr
csf
hiv
patient
rare
detect
hivinfect
patient
without
clinic
neurolog
diseas
cmv
viral
load
test
use
pcr
techniqu
includ
realtim
pcr
hybrid
captur
assay
detect
quantifi
cmv
dna
dnarna
hybrid
clinic
specimen
includ
csf
cmv
viral
load
assay
perform
quickli
import
use
assay
monitor
individu
patient
interpret
result
viral
load
sometim
problemat
unclear
cmv
viral
load
standard
possibl
defin
cutoff
valu
herp
simplex
viru
hsv
caus
wide
spectrum
clinic
manifest
cn
genit
dermal
diseas
hsv
common
caus
nonepidem
sporad
acut
focal
cn
diseas
mainli
enceph
hsv
also
caus
asept
mening
usual
selflimit
diseas
resolv
without
specif
therapi
need
rapid
accur
diagnost
test
hsv
cn
diseas
csf
pcr
test
evalu
diagnost
test
hsv
enceph
mening
rapid
high
sensit
specif
diagnost
tool
howev
neither
sensit
specif
hsv
pcr
result
interpret
caution
falseneg
hsv
pcr
result
could
possibl
falseposit
hsv
pcr
result
also
possibl
due
eventu
contamin
even
current
establish
molecular
amplif
hsv
dna
new
gold
standard
laboratori
diagnosi
infect
pcr
posit
earli
cours
ill
within
first
hour
remain
posit
first
week
therapi
case
viral
genom
persist
csf
two
week
longer
onset
antivir
therapi
realtim
pcr
assay
use
diagnosi
cmv
ebv
vzv
csf
specimen
compar
convent
pcr
realtim
assay
rapid
simpl
conveni
test
herpesvirus
dna
routin
laboratori
similar
clinic
featur
virus
reason
includ
sever
target
csf
test
rather
singl
uniqu
sequenc
one
viru
respect
dermal
genit
diseas
caus
hsv
realtim
hsv
pcr
assay
emerg
sensit
method
confirm
hsv
infect
clinic
specimen
obtain
genit
ulcer
mucocutan
lesion
convent
pcr
adapt
detect
hsv
dermal
genit
sourc
cell
cultur
direct
stain
techniqu
rel
sensit
detect
hsv
specimen
main
limit
factor
introduc
realtim
hsv
pcr
primari
diagnost
tool
laboratori
cost
assay
moreov
lack
uniform
valid
pcr
assay
diagnost
method
detect
hsv
clinic
specimen
cerebrospin
fluid
limit
avail
laboratori
vzv
caus
cn
diseas
enceph
myeliti
acut
mening
retrospect
studi
vzv
dna
detect
csf
specimen
realtim
pcr
assay
provid
rapid
sensit
confirm
vzv
clinic
specimen
obtain
sever
sampl
exud
skin
lesion
bronchoalveolar
lavag
csf
sever
studi
compar
differ
assay
realtim
pcr
demonstr
vzv
dna
detect
sampl
rest
techniqu
moreov
pcrbase
test
highli
specif
crossreact
identifi
test
sever
virus
pcr
test
also
use
indic
diagnosi
vzv
infect
patient
vaccinemodifi
infect
well
test
serum
blood
might
also
help
transplant
patient
viscer
diseas
prior
appear
cutan
lesion
ebv
implic
develop
lymphoma
immunosupress
patient
detect
ebv
dna
molecular
techniqu
csf
could
use
diagnosi
infect
techniqu
sensit
specif
approach
detect
ebv
dna
might
also
use
patient
brain
biopsi
possibl
hand
detect
ebv
dna
csf
also
provid
marker
monitor
respons
treatment
cn
lymphoma
ebv
dna
detect
convent
pcr
situ
hybrid
also
recent
introduc
realtim
pcr
assay
detect
ebv
dna
cn
lymphoma
infect
parvoviru
might
caus
asymptomat
infect
wide
spectrum
diseas
erythema
infectiosum
children
arthropathi
sever
anemia
system
affect
well
hydrop
fetali
congenit
anemia
abort
infect
produc
pregnant
women
although
parvoviru
infect
diagnos
serolog
detect
igm
igg
class
antibodi
elisa
assay
main
applic
dna
detect
pcr
control
transmiss
viru
present
blood
detect
dna
use
molecular
test
use
mani
clinic
laboratori
techniqu
much
sensit
antigenbas
detect
system
techniqu
detect
genotyp
dna
genotyp
realtim
pcr
assay
lightcycl
parvoviru
quantit
assay
roch
diagnost
indianapoli
abi
taqman
appli
biosystem
develop
detect
nucleic
acid
associ
infect
pregnanc
assess
preval
viru
dna
blood
product
lightcycl
parvoviru
quantit
assay
highli
sensit
genotyp
suitabl
detect
genotyp
respect
realart
parvo
lc
pcr
qiagen
hamburg
assay
detect
three
genotyp
accord
research
other
appropri
clinic
specimen
nucleic
acid
analysi
includ
plasma
serum
bone
marrow
placent
fetal
tissu
amniot
fluid
virus
recov
cell
cultur
bk
viru
associ
nephropathi
renal
transplant
patient
well
patient
ureter
stenosi
hematuria
hand
well
know
associ
jc
viru
infect
progress
multifoc
leukoencephalopathi
immunocompromis
patient
aid
convent
pcr
detect
jc
viru
cerebrospin
fluid
replac
brain
biopsi
diagnosi
presenc
viru
patient
leukoencephalopathi
techniqu
sensit
rang
specif
rang
highli
activ
antiretrovir
therapi
howev
moment
applic
therapi
recoveri
immun
system
viral
replic
becom
decreas
jc
viru
pcr
neg
csf
current
develop
qualit
realtim
pcr
jc
viru
detect
csf
bk
viru
detect
urin
sampl
convent
pcr
also
quantit
realtim
pcr
techniqu
develop
monitor
bk
viru
dna
renal
transplant
recipi
activ
bk
viru
nephropathi
associ
high
quantit
level
bk
viru
dna
resolut
nephropathi
correl
decreas
dna
viru
level
urin
howev
although
sensit
test
presenc
bk
viru
dna
kind
sampl
necessarili
mean
true
infect
asymptomat
reactiv
infect
renal
transplant
patient
therefor
result
confirm
use
blood
sampl
sens
research
demonstr
renal
transplant
recipi
higher
urin
dna
level
like
show
detect
dna
blood
hand
neg
result
mean
associ
bk
viru
nephriti
final
pcr
kidney
biopsi
specimen
appropri
test
primari
diagnosi
bk
nephropathi
persist
lowlevel
target
dna
biopsi
specimen
detect
asymptomat
patient
rapid
laboratori
diagnosi
critic
infect
control
sever
diagnost
test
develop
avail
detect
influenza
virus
rapid
influenza
diagnost
test
less
sensit
specif
fluoresc
antibodi
assay
rtpcr
rtpcr
prefer
diagnost
assay
influenza
viru
test
sensit
specif
differenti
influenza
type
b
subtyp
main
problem
techniqu
could
avail
laboratori
need
test
set
realtim
pcr
much
sensit
method
detect
avail
detect
influenza
viru
expens
respect
parainfluenza
virus
type
associ
bronchiol
croup
pneumonia
children
also
elderli
immunocompromis
patient
pcr
adequ
techniqu
detect
parainfluenza
viru
immunocompromis
patient
pcr
sensit
specif
rang
compar
cultur
method
multiplex
pcr
assay
differenti
wide
varieti
respiratori
pathogen
also
rapid
sensit
multiplex
realtim
pcr
assay
detect
four
serotyp
parainfluenza
virus
develop
inform
see
articl
entitl
laboratori
detect
respiratori
virus
autom
techniqu
pcr
specif
sensit
assay
detect
adenoviru
dna
wide
varieti
clinic
specimen
result
must
alway
interpret
context
clinic
find
adenoviru
diseas
quantit
realtim
pcr
use
evalu
adenoviru
infect
immunocompromis
patient
moreov
quantif
adenoviru
dna
could
use
assess
respons
antivir
therapi
realtim
pcr
assay
mainli
use
detect
adenoviru
type
subgroup
e
caus
respiratori
ocular
infect
sensit
real
time
pcr
convent
pcr
greater
detect
adenoviru
dna
enterovirus
echovirus
parechovirus
echovirus
coxsackievirus
b
could
produc
sever
diseas
respiratori
tract
infect
asept
mening
myocard
neonat
system
enterovir
diseas
cell
cultur
low
sensit
molecular
techniqu
like
rtpcr
develop
diagnosi
kind
virus
moreov
rtpcr
higher
sensit
cell
cultur
detect
enterovirus
csf
rapid
sensit
detect
enteroviru
csf
could
perform
introduct
realtim
pcr
techniqu
laboratori
realtim
pcr
assay
amplifi
conserv
target
nucleic
acid
sequenc
viru
sensit
detect
enteroviru
similar
convent
pcr
realtim
pcr
last
one
less
labor
intens
easier
implement
clinic
laboratori
molecular
techniqu
use
diagnosi
viral
hepat
infect
hepat
b
c
e
case
serolog
assay
conclus
howev
current
main
applic
nucleic
acid
test
manag
virus
hepat
b
c
detect
serum
plasma
viral
load
virus
monitor
therapeut
respons
infect
patient
assay
quantifi
hepat
b
c
viru
load
liver
tissu
also
describ
hbv
dna
detect
hbv
dna
viral
load
also
essenti
explor
viral
reactiv
realtim
pcr
quantif
assay
wide
use
sensit
specif
accuraci
broad
dynam
rang
posit
predict
valu
world
health
organ
defin
intern
standard
howev
techniqu
use
hbv
primer
follow
patient
carri
technic
assay
order
compar
viral
dna
load
evolut
respect
hbv
genotyp
current
need
perform
due
sever
factor
predict
clinic
outcom
associ
respons
interferon
treatment
genotyp
chronic
hbv
infect
help
practic
physician
identifi
risk
diseas
progress
determin
optim
antivir
therapi
method
determin
viral
genotyp
base
hybrid
sequenc
genotyp
affili
reli
phylogenet
analys
respect
hcv
molecular
diagnost
assay
repres
essenti
approach
manag
hcv
patient
qualit
quantit
hcv
molecular
assay
use
diagnosi
acut
chronic
hcv
infect
viral
genotyp
viralload
determin
treatment
monitor
prognosi
rtpcr
transcriptionmedi
amplif
branch
dna
amplif
commonli
employ
detect
hcv
rna
recent
new
hcv
molecular
assay
employ
nanostructur
emerg
propos
suitabl
without
loss
specif
sensit
inform
see
articl
entitl
introduct
autom
system
diagnosi
quantif
hepat
b
hepat
c
virus
rna
level
plasma
infect
patient
could
detect
quantit
rapid
realtim
pcr
assay
techniqu
detect
similar
sensit
specif
differ
probe
amplificationdetect
system
use
quantit
assay
measur
provir
dna
also
develop
well
qualit
realtim
pcr
assay
detect
provir
dna
inform
see
articl
entitl
improv
clinic
laboratori
effici
introduct
system
diagnosi
monitor
hiv
infect
molecular
method
detect
hpv
dna
clinic
specimen
introduc
clinic
practic
major
protocol
detect
infect
current
base
studi
hpv
dna
hpv
dna
detect
could
carri
sever
method
typespecif
pcr
pcr
gener
primer
liquid
hybrid
hybrid
captur
sever
studi
shown
util
hpv
dna
test
manag
women
abnorm
pap
smear
identifi
women
high
risk
test
hpv
dna
could
avoid
unnecessari
colposcopi
procedur
inform
see
articl
entitl
human
papillomaviru
hpv
genotyp
autom
applic
routin
laboratori
test
main
goal
clinic
virolog
laboratori
assist
clinician
diagnosi
treatment
viral
diseas
support
infect
control
specialist
task
need
rapid
identif
etiolog
microorgan
effect
patient
manag
sinc
molecular
techniqu
detect
nucleic
acid
develop
diagnosi
sever
viral
diseas
revolution
clinic
laboratori
major
introduc
method
routin
diagnosi
use
refer
set
main
advantag
molecular
techniqu
higher
sensit
specif
compar
diagnost
method
serolog
assay
cultur
method
well
rapid
possibl
autom
epidemiolog
clinic
point
view
featur
import
diagnosi
diseas
cn
infect
detect
microorgan
faster
order
treat
rapidli
patient
isol
prevent
viral
transmiss
diseas
among
fact
autom
also
permit
perform
much
assay
rapid
help
improv
patient
diagnosi
virolog
laboratori
clinic
diagnosi
introduc
techniqu
order
determin
main
virus
implic
human
diseas
analysi
cost
laboratori
director
technic
coordin
establish
workflow
techniqu
enhanc
effici
test
method
workflow
done
individu
way
take
account
assay
introduc
special
characterist
laboratori
moreov
personnel
train
accord
best
practic
methodolog
time
author
declar
compet
interest
